Health Services Research
Latest posts by Health Services Research (see all)
- Physician Engagement Strategies in Care Coordination: Findings from the Centers for Medicare… - Dec. 02, 2016
- The Effect of Certificate of Need Laws on All-Cause Mortality - Dec. 02, 2016
- Using Harm-Based Weights for the AHRQ Patient Safety for Selected Indicators Composite… - Nov. 28, 2016
- Are Two Heads Better Than One or Do Too Many Cooks Spoil the Broth? The Trade-Off between… - Nov. 28, 2016
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: